1. 1850 Safety of everolimus plus exemestane in elderly patients with Hormone-Receptor-Positive (HR+), HER2- locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors (NSAIs): BALLET (CRAD001YIC04). (September 2015) Authors: Neven, P.; Generali, D.; Ciruelos, E.M.; Lang, I.; Gavila, J.G.; Bighin, C.; Borms, M.; Conte, P.; Montemurro, F.; Sartori, D.; Lee, T.V.; Camozzi, M.; Lorizzo, K.; Ocak, O.; Jerusalem, G. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S282 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 5-yr DMFS outcomes on the pre-operative use of MammaPrint and BluePrint for neoadjuvant decisions in the NBREaST II trial. (April 2021) Authors: Göker, E.; Hendriks, M.P.; van Tilburg, M.; Barcaru, A.; Mittempergher, L.; van Egmond, A.; Kleijn, M.; Generali, D. Journal: Breast Issue: Volume 56(2021)Supplement 1 Page Start: S53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Chemosensitivity and endocrine sensitivity predicted by combining the 80-gene signature and 70-gene signature in the prospective Neoadjuvant Breast Registry Europe – Symphony Trial (NBREaST II). (April 2018) Authors: Göker, E.; De Roos, M.; Hendriks, M.; Van Tilburg, M.; Dreezen, C.; Stork-Sloots, L.; Van Egmond, A.; Neijenhuis, S.; Generali, D. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study. (October 2017) Authors: Alù, M.; Ancona, C.; Andreis, D.; Bajardi, E.; Benedetto, C.; Berardi, R.; Bordin, E.; Butti, C.; Capri, G.; Cicchiello, F.; Cocciolone, V.; Dester, M.; D'Onofrio, L.; Febbraro, A.; Ferrarini, I.; Fotia, V.; Gervasi, E.; Guaitoli, G.; Licata, L.; Liscia, N. Journal: Breast Issue: Volume 35(2017) Page Start: 115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy of extended aromatase inhibitors for hormone-receptor–positive breast cancer: A literature-based meta-analysis of randomized trials. (August 2019) Authors: Corona, S.P.; Roviello, G.; Strina, C.; Milani, M.; Madaro, S.; Zanoni, D.; Allevi, G.; Aguggini, S.; Cappelletti, M.R.; Francaviglia, M.; Azzini, C.; Cocconi, A.; Sirico, M.; Bortul, M.; Zanconati, F.; Giudici, F.; Rosellini, P.; Meani, F.; Pagani, O.; Generali, D. Journal: Breast Issue: Volume 46(2019) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Evaluation of circulating cell-free DNA and its integrity as a potential predictive biomarker of breast cancer onset: A pilot study. (October 2020) Authors: Scaggiante, B.; Giudici, F.; Zanconati, F.; Bottin, C.; Revoltella, C.; Corona, S.; Cappelletti, M.; Generali, D.; Bortul, M. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: A retrospective exploratory analysis of the BALLET study. (October 2020) Authors: Corona, S.; Giudici, F.; Jerusalem, G.; Ciruelos, E.; Strina, C.; Sirico, M.; Bernocchi, O.; Milani, M.; Dester, M.; Ziglioli, N.; Barbieri, G.; Cervoni, V.; Montemurro, F.; Generali, D. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study. (December 2019) Authors: Cazzaniga, M.E.; Pinotti, G.; Montagna, E.; Amoroso, D.; Berardi, R.; Butera, A.; Cagossi, K.; Cavanna, L.; Ciccarese, M.; Cinieri, S.; Cretella, E.; De Conciliis, E.; Febbraro, A.; Ferraù, F.; Ferzi, A.; Fiorentini, G.; Fontana, A.; Gambaro, A.R.; Garrone, O.; Gebbia, V. Journal: Breast Issue: Volume 48(2019) Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Need for randomized clinical trials testing targeted therapies in malignant pleural mesothelioma. (December 2017) Authors: Sobhani, N.; Roviello, G.; Corona, S.P.; Ianza, A.; Zanconati, F.; Generali, D. Journal: Lung cancer Issue: Volume 114(2017) Page Start: 103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review. (March 2023) Authors: Miglietta, F.; Fabi, A.; Generali, D.; Dieci, M.V.; Arpino, G.; Bianchini, G.; Cinieri, S.; Conte, P.F.; Curigliano, G.; De Laurentis, M.; Del Mastro, L.; De Placido, S.; Gennari, A.; Puglisi, F.; Zambelli, A.; Perrone, F.; Guarneri, V. Journal: Cancer treatment reviews Issue: Volume 114(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗